Comparison of the α-Amylase Inhibitor-1 from Common Bean (Phaseolus vulgaris) Varieties and Transgenic Expression in Other Legumes—Post-Translational Modifications and Immunogenicity
2011
J. Agric. Food Chem., 2011, 59 (11), pp 6047–6054 DOI: 10.1021/jf200456j
Peter M. Campbell*†, Daniela Reiner‡, Andrew E. Moore§, Rui-Yun Lee‡, Michelle M. Epstein‡, and T. J. V. Higgins§ † CSIRO Ecosystem Sciences, P.O. Box 1700, Canberra, ACT, 2601, Australia ‡ Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases, Medical University of Vienna, Austria § CSIRO Plant Industry, P.O. Box 1600, Canberra, ACT, 2601, Australia
The seeds of peas (Pisum sativum) and chickpeas (Cicer arietinum) expressing a gene for α-amylase inhibitor-1 (αAI) from the common bean (Phaseolus vulgaris) are protected from damage by old world bruchids (pea and cowpea weevils). Here, we used electrospray ionization time-of-flight mass spectrometry to compare the post-translational modifications of αAI from transgenic sources with the processed forms of the protein from several bean varieties. All sources showed microheterogeneity with differences in the relative abundance of particular variants due to differences in the frequency of addition of glycans, variable processing of glycans, and differences of C-terminal exopeptidase activity. The structural variation among the transgenics was generally within the range of the bean varieties. Previously, mice showed allergic reactions following ingestion of transgenic pea αAI but not bean αAI. Here, only minor differences were observed following intraperitoneal sensitization. Both of the transgenic pea and bean forms of αAI elicited Th1 and Th2 antibody isotype responses, suggesting that both proteins are immunogenic and could potentially be allergenic.